Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144: II. Biological activities

Journal of Antibiotics

Volumn 61, Issue 1, 2008, Pages 7-10

  Fukumoto, Atsushi ^a   Kim, Yong Pil ^b   Hanaki, Hideaki ^b   Shiomi, Kazuro ^a   Tomoda, Hiroshi ^a,b   Omura, Satoshi ^a,b  

^a KITASATO UNIVERSITY   (Japan)

^b KITASATO INSTITUTE   (Japan)

Author keywords

lactam; Cyslabdan; Imipenem potentiator; Methicillin resistant Staphylococcus aureus; MRSA; Streptomyces sp. K04 0144

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BIAPENEM; CARBAPENEM DERIVATIVE; CEFALEXIN; CEFAZOLIN; CEFMETAZOLE; CEFOTAXIME; CIPROFLOXACIN; CLOXACILLIN; CYSLABDAN; IMIPENEM; MEROPENEM; PANIPENEM; PENICILLIN G; STREPTOMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN; ACETYLCYSTEINE; ANTIINFECTIVE AGENT; BETA LACTAM; DITERPENE; DRUG DERIVATIVE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BIOLOGICAL ACTIVITY; DRUG POTENTIATION; DRUG STRUCTURE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STREPTOMYCES; BIOSYNTHESIS; CHEMICAL STRUCTURE; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGICAL EXAMINATION; PENICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STREPTOMYCES SP.;

ACETYLCYSTEINE; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CARBAPENEMS; DITERPENES; DRUG SYNERGISM; HUMANS; IMIPENEM; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; STAPHYLOCOCCUS AUREUS; STREPTOMYCES;

EID: 44649122131     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2008.102     Document Type: Article

References (7)

1. Fukumoto A, Kim YP, Matsumoto A, Takahashi Y, Shiomi K, Tomoda H, Ōmura S. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144 1. Taxonmy, fermentation, isolation and structural elucidation. J Antibiot 61: 1-6 (2008)
2. Committee for Antimicrobial Susceptibility Testing Method. Standard methods of Japanese Society of Chemotherapy. Chemotherapy 38: 102-105 (1990) (in Japanese)
3. Fukuda N, Yamase T, Tajima Y. Inhibitory effect of polyoxotungstates on the production of penicillin-binding proteins and β-lactamase against methicillin-resistant Staphylococcus aureus. Biol Pharm Bull 22: 463-470 (1999)
4. Zhao WH, Hu ZQ, Okubo S, Hara Y, Shimamura T. Mechanism of synergy between epigallocatechin gallate and β-lactams against methicillin- resistant Staphylococcus aureus. Antimicrob Agents Chemother 45: 1737-1742 (2001)
5. Shiota S, Shimizu M, Sugiyama J, Morita Y, Mizushima T, Tsuchiya T. Mechanisms of action of corilagin and tellimagrandin I that remarkably potentiate the activity of β-lactams against methicillin-resistant Staphylococcus aureus. Microbiol Immunol 48: 67-73 (2004)
6. Nicolson K, Evans G, O'Toole PW. Potentiation of methicillin activity against methicillin-resistant Staphylococcus aureus by diterpenes. FEMS Microbiol Lett 179: 233-239 (1999)
7. Chamberland S, Blais J, Boggs AF, Bao Y, Malouin F, Hecker SJ, Lee VJ. MC-207, 252 Abolishes PBP2a mediated β-lactam resistance in Staphylococci. Abstract in 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). pp. F138-F144 (1995)